Type O blood is often called the “universal donor” type because it lacks both A and B antigens, but it is not truly antigen-free. Red blood cells in people with type O still carry the H antigen, a precursor sugar that serves as the foundation for the entire ABO system. To find blood that is genuinely missing more antigens, you have to look at rarer conditions: the Bombay phenotype, which lacks A, B, and H antigens altogether, and Rhnull, sometimes called “golden blood,” which is missing all antigens from the separate Rh blood group system. These phenotypes sit at opposite ends of a spectrum of antigen absence, and each comes with its own medical complications.
Why Type O Is Not Really “No Antigens”
The ABO blood group system is built on three antigens: A, B, and H. The H antigen is a carbohydrate structure that sits on the surface of red blood cells and acts as the raw material from which A and B antigens are made. Enzymes called glycosyltransferases attach additional sugars to the H antigen, converting it into either the A antigen or the B antigen depending on which enzyme a person inherited. People with type A blood have the A enzyme, people with type B have the B enzyme, people with type AB have both, and people with type O have neither.1Transfusion Medicine and Hemostasis. ABO and H Blood Group System
Because type O individuals lack both the A and B enzymes, their H antigen goes unconverted. That means type O red blood cells are actually coated in large amounts of H antigen. The designation is sometimes written as O(H) to make this explicit.2PubMed Central. ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies So while type O blood won’t trigger a reaction in someone who has anti-A or anti-B antibodies, it is far from immunologically blank. The H antigen is a real antigen, and in rare circumstances, antibodies directed against it can cause serious transfusion problems.
The Bombay Phenotype and True ABO Emptiness
If you want red blood cells stripped of A, B, and H antigens, you need to look at the Bombay phenotype. First identified in Mumbai (then Bombay) in 1952, this condition arises when a person inherits mutations in the FUT1 gene, which encodes the enzyme responsible for building the H antigen in the first place. Without functional H antigen, there is nothing for the A or B enzymes to work on, so all three antigens are absent from the red cell surface.3PubMed Central. Blood groups systems
Bombay individuals produce anti-A, anti-B, and anti-H antibodies. That last one is the clinically dangerous surprise. Because virtually all donated blood contains H antigen, even type O blood is incompatible. A person with the Bombay phenotype can safely receive blood only from another Bombay donor. In routine pre-transfusion testing, their serum will react with every panel cell it encounters, a pattern that initially looks like an error but is in fact the signature of the phenotype.4PubMed Central. Peri-operative red cell transfusion management in a rare H-deficient (Para-Bombay) blood group variant
The genetic basis is well characterized. Bombay individuals are homozygous for inactivating mutations in FUT1, and many also carry deletions or mutations in the related FUT2 gene. Studies from Iran have identified novel FUT1 mutations alongside FUT2 deletions in families with the phenotype.5PubMed. Identification of two novel FUT1 mutations in people with Bombay phenotype from Iran A database cataloging FUT1 variants found that both Bombay and the closely related para-Bombay phenotype result from absent or very weak activity of the enzyme encoded by FUT1.6Scientific Reports. FUT1 variants responsible for Bombay or para-Bombay phenotypes in a database
Para-Bombay is worth a quick distinction. Where Bombay is a complete loss of H antigen, para-Bombay involves partial loss. People with para-Bombay may have trace amounts of H antigen on their cells or H substance detectable in their saliva. Both phenotypes stem from point mutations in FUT1, but the clinical consequences differ: para-Bombay individuals sometimes tolerate carefully selected donor blood, while Bombay individuals generally cannot.4PubMed Central. Peri-operative red cell transfusion management in a rare H-deficient (Para-Bombay) blood group variant
Rhnull and the Total Absence of Rh Antigens
The ABO system is one blood group system; the Rh system is an entirely separate one. Most people are familiar with the D antigen, the one that determines whether you are “Rh positive” or “Rh negative.” But the Rh system actually encompasses over 50 antigens, the most clinically important being D, C, c, E, and e. These are carried on two transmembrane proteins, RhD and RhCE, each made of 417 amino acids and predicted to loop through the red cell membrane twelve times.7PubMed Central. Review: the molecular basis of the Rh blood group phenotypes
Rhnull individuals have none of these. Every single Rh antigen is absent from their red blood cells. Fewer than 50 people worldwide have been confirmed with this phenotype, which is why it has earned the nickname “golden blood.” The condition can arise in two ways genetically. In the “amorph” type, mutations knock out both the RHD and RHCE genes directly. In the “regulator” type, the RHD and RHCE genes are intact, but mutations in the RHAG gene prevent the Rh proteins from being properly assembled on the cell surface. A recent case report identified a novel frameshift deletion in exon 5 of RHAG that created a premature stop signal, completely halting production of the Rh-associated glycoprotein.8PubMed. Rh(null) blood group caused by novel base deletion and comprehensive pedigree analysis
It is worth noting that Rhnull refers specifically to the Rh system. Someone with Rhnull still has ABO antigens, still has H antigen, and still carries antigens from dozens of other blood group systems. The name is dramatic, but it does not mean the red cells are antigen-free in a total sense. It means they are Rh-antigen-free, which is dramatic enough given that the Rh system is the second most clinically important blood group after ABO.
What Happens When You Have No Rh Antigens
The Rh proteins are not just antigen carriers. They play a structural role in maintaining the shape and stability of the red blood cell membrane. When those proteins are missing, the membrane does not hold together as well as it should. Clinical reports of Rhnull individuals consistently describe a syndrome of mild to moderate hemolytic anemia, meaning their red blood cells break down faster than normal. The cells often appear spherical (spherocytosis) or show mouth-shaped indentations (stomatocytosis) under the microscope, and they are abnormally fragile when exposed to changes in salt concentration.9PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran
For most Rhnull individuals, this anemia is manageable. The body compensates by producing red cells at a higher rate, and many people live relatively normal lives with slightly lower hemoglobin levels. The real problem is not day-to-day health but what happens when they need a blood transfusion. An Rhnull person who receives blood containing any Rh antigens risks developing antibodies against those antigens, particularly a broad antibody called anti-Rh29 that reacts against essentially all Rh-positive cells. Once formed, this antibody makes virtually every unit of donated blood in the world incompatible.
Transfusion Challenges for the Rarest Phenotypes
For both Bombay and Rhnull individuals, the transfusion problem is the same in kind but different in scale. Bombay donors are rare but not impossibly so, particularly in parts of South Asia where the phenotype is most common. Rhnull donors are measured in the dozens worldwide.
Pregnancy adds another layer of risk. A review of published cases found that Rhnull women face unique challenges because they can develop antibodies against high-prevalence Rh antigens during pregnancy, potentially causing hemolytic disease of the fetus and newborn. Anti-Rh29 was explicitly reported in several of these cases, and other reports described broad antibody patterns consistent with the same mechanism. Compatible blood for either the mother or the newborn is extremely difficult to source.10Transfusion Medicine. Managing pregnancy in women with the Rh-null phenotype: A structured narrative review of alloimmunisation, maternal-fetal outcomes and transfusion management
Rare blood donor programs exist to address situations like these. The American Rare Donor Program, jointly managed by the American Red Cross and the American Association of Blood Banks, maintains a database of donors with rare phenotypes and stockpiles frozen rare blood. A similar program operates in Europe under the European Directorate for Quality of Medicines and Healthcare.11PubMed Central. Rare blood donor program in the country: Right time to start Frozen red cells can be stored for years, which helps, but the logistics of shipping a rare unit across continents in an emergency remain daunting. Some Rhnull individuals bank their own blood in advance of planned surgeries as a precaution.
Engineering Blood That Works for Everyone
The scarcity of truly compatible blood for people with rare phenotypes has pushed researchers toward a different question: instead of finding antigen-negative donors, can you strip the antigens off of normal donated blood? Three broad approaches are in active development.
Enzymatic Antigen Removal
The most advanced strategy uses enzymes to clip the sugar antigens off of red blood cells, converting type A or B blood into something functionally resembling type O. Researchers screened the human gut microbiome and identified an enzyme pair from the bacterium Flavonifractor plautii that works in concert to efficiently convert the A antigen into the H antigen of O type blood, via a galactosamine intermediate.12Nature Microbiology. An enzymatic pathway in the human gut microbiome that converts A to universal O type blood One enzyme deacetylates the terminal sugar of the A antigen, and the second enzyme cleaves the resulting sugar off, leaving behind the H antigen. This pair requires roughly 15 to 30 times less enzyme than earlier approaches and works well in whole blood at room temperature.13PubMed Central. Toward universal donor blood: Enzymatic conversion of A and B to O type
More recently, researchers turned to another gut bacterium, Akkermansia muciniphila, which naturally breaks down mucin sugars that share structural features with blood group antigens. Out of 23 glycosyl hydrolases evaluated, specific combinations efficiently converted both A and B antigens along with four of their carbohydrate extensions. Removing these extended antigens significantly improved compatibility with group O plasma compared to removing only the canonical A or B sugars.14Nature Microbiology. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood This is a meaningful advance because earlier enzymatic methods sometimes left behind subtle carbohydrate extensions that could still trigger immune reactions.
Polymer Camouflage
A different approach leaves the antigens in place but hides them behind a physical shield. By chemically attaching chains of polyethylene glycol (PEG) to the surface of red blood cells, researchers have demonstrated that blood group reactivity can be suppressed. Early work showed that PEG-coated human red blood cells lost their ABO reactivity in standard antibody testing, and PEG-coated animal red cells resisted being eaten by human immune cells.15PubMed. Chemical camouflage of antigenic determinants: stealth erythrocytes Later refinements found that PEG chains of about 5,000 molecular weight effectively masked Rh system antigens like C, c, E, e, and D. Masking the larger A and B antigens required a combination of shorter and longer PEG chains working together.16PubMed. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane
Branched polymer architectures have also been tested. Hyperbranched polyglycerol (HPG) and linear PEG of similar sizes were compared head-to-head for their ability to shield antigens. PEG generally provided better overall shielding of ABO and minor antigens, though the more compact HPG polymers offered stronger protection for certain specific antigens.17PubMed. Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells Neither approach has reached clinical use yet, but the concept of a physical antigen shield is appealing because it could theoretically mask antigens across multiple blood group systems simultaneously.
Silicification and Hemoglobin-Based Carriers
A more exotic approach encases entire red blood cells in a thin shell of amorphous silica, physically preventing antibodies from reaching the cell surface. Silicified red cells demonstrated universal compatibility in lab tests because the silica layer blocked epitope recognition entirely.18Cell Press (Matter). Artificially engineered red blood cells for universal blood transfusion Meanwhile, an entirely cell-free strategy uses hemoglobin-based oxygen carriers, synthetic preparations that carry oxygen using purified hemoglobin rather than intact red cells. Because they contain no cell membrane, they are inherently free of blood group antigens and pathogens.19PubMed Central. Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics These products remain largely experimental, with challenges around shelf life, toxicity from free hemoglobin, and the loss of other functions that intact red cells perform.
Why Blood Type O Became So Common
Given that type O blood lacks A and B antigens and therefore cannot be rossetted as effectively by the malaria parasite Plasmodium falciparum, there has long been interest in whether malaria shaped the global distribution of ABO blood types. Rosetting is a process where infected red blood cells stick to uninfected ones, forming clumps that help the parasite evade the immune system and block small blood vessels. Research has shown that type O blood reduces rosetting and protects against severe malaria, suggesting that the selective pressure of malaria may have driven up the frequency of the O allele in populations where malaria was historically endemic.20PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting
This fits with the global pattern: type O is most common in Central and South America, parts of Africa, and other regions with heavy historical malaria burden. In areas where malaria was less of a threat, type A and B frequencies tend to be higher. The relationship is not perfectly clean, because diet, migration, genetic drift, and other infectious diseases all played roles too, but malaria appears to be one of the strongest selective forces that pushed populations toward the O phenotype.
Blood Groups Are Ancient and Shared Across Primates
The ABO blood group system is not a human invention. A sweeping genetic analysis of 40 non-human primate species found that the ABO polymorphism is ancient and widespread. Nineteen species across ten genera carried both A and B alleles, and fifteen species across eleven genera had an unambiguous O allele as well. Even more striking, the genetic basis for A versus B specificity turned out to be the same in New World monkeys (like marmosets) as in apes, meaning the system has been maintained across primate evolution for tens of millions of years rather than evolving independently in different lineages.21PubMed Central. The ABO blood group is a trans-species polymorphism in primates
The Rh system has a similarly deep evolutionary history. By sequencing intron regions of Rh genes in various primates, researchers found that a particular genetic element was inserted into the Rh gene of the common ancestor of humans, apes, Old World monkeys, and New World monkeys. Chimpanzees and gorillas, like humans, possess two types of Rh intron sequences, corresponding to the RHD and RHCE gene pair that gives rise to the Rh antigen diversity we see today.22Molecular Biology and Evolution. Rh Gene Evolution in Primates: Study of Intron Sequences The persistence of both ABO and Rh diversity over such vast timescales suggests that carrying a mix of blood group antigens within a population confers survival advantages, possibly by making it harder for a single pathogen to exploit one universal surface molecule across all hosts.
That evolutionary logic makes rare null phenotypes especially interesting. Bombay and Rhnull represent what happens when those carefully maintained antigen systems break down in an individual. The red cells function well enough to sustain life, but the loss of antigens creates fragile membranes in the case of Rhnull, and catastrophic transfusion incompatibility in both cases. The fact that these phenotypes remain vanishingly rare despite recurring through new mutations in every generation tells you something about the cost of losing them entirely.